disodium (4R,5R,6S)-3-[(3S,5S)-5-[(3-carboxylatophenyl)carbamoyl]pyrro lidin-3-yl]sulfanyl-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo[3.2 .0]hept-2-ene-2-carboxylate(CAS: 153832-38-3)

This compound (CAS: 153832-38-3) falls under the scope of the REACH regulation in the EU, requiring registration for substances above 1 tonne per year. It may also be regulated under the TSCA in the USA. GHS classification is recommended for hazardous communication, and FDA and EPA have specific guidelines for chemical substances used in pharmaceuticals and agricultural products respectively.

Alternatives to this compound may include related analogs such as simpler derivatives or isomers. Common alternative reagents in synthesis include amino acids or carboxylic acids. However, the choice of alternatives depends on the specific application and desired properties.

The compound (CAS: 153832-38-3) is currently trending in research for its potential in medicinal chemistry. Market demand is driven by its use in pharmaceutical applications, particularly in anti-inflammatory and analgesic drugs. Research is also exploring its synthetic versatility in creating novel compounds.

Waste containing this compound (CAS: 153832-38-3) should be collected in sealed containers and stored in a secure area. Professional waste disposal methods, such as incineration or chemical treatment, should be employed. Environmental protection measures must be taken to prevent contamination of soil and water. Compliance with local and international regulations is essential.